GLP-1s and Fertility in Men: What the Research Says
Key Takeaways
- No published evidence that GLP-1 medications directly harm male fertility or sperm quality
- Obesity itself impairs fertility — GLP-1 weight loss may improve sperm parameters by reducing obesity-related hormonal disruption
- Testosterone increase from fat loss can improve both libido and sperm production
- Unlike TRT (which suppresses sperm production), GLP-1s do not suppress the HPG axis
- Men planning to conceive should discuss timing with their provider — though no washout period is established for men
Women are advised to stop GLP-1s before pregnancy, but what about men? The picture for male fertility is more reassuring — and potentially even positive.
GLP-1s vs. TRT: A Fertility Comparison
| Factor | GLP-1 Medications | TRT |
|---|---|---|
| Effect on sperm production | No suppression documented | Suppresses spermatogenesis |
| Effect on HPG axis | No suppression | Suppresses LH/FSH |
| Effect on testosterone | Indirect increase (fat loss) | Direct increase |
| Fertility-safe? | Yes — based on current evidence | No — not during conception attempts |
This is one of GLP-1s' underappreciated advantages for men: unlike TRT, they don't suppress the hypothalamic-pituitary-gonadal axis. Men can use GLP-1s while trying to conceive without the fertility concerns that come with exogenous testosterone.
Current evidence shows no direct fertility harm from GLP-1 medications in men. The weight loss itself likely improves fertility by normalizing hormones and reducing inflammation. For men who need both weight loss and fertility preservation, GLP-1s are a safer choice than TRT. Discuss your specific situation with your provider, but the data so far is reassuring.
GLP-1Men Editorial
Male-focused GLP-1 research. Testosterone, muscle preservation, and men's metabolic health. Not medical advice.